Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death

Marc Humbert

INSERM, UMR_S 999, Pulmonary Hypertension: Pathophysiology and Novel Therapies (HPPIT)

Vallerie V. McLaughlin

University of Michigan Medical School, Ann Arbor

David B. Badesch

University of Colorado, Anschutz Medical Campus, Aurora

H. Ardeschir Ghofrani

Department of Internal Medicine, Justus-Liebig University Giessen, Universities of Giessen and Marburg Lung Center, Member of the German Center for Lung Research, Giessen, Germany

J. Simon R. Gibbs

National Heart and Lung Institute, Imperial College London, London

Mardi Gomberg-Maitland

George Washington University School of Medicine and Health Sciences, Washington, DC

Ioana R. Preston

Lahey Hospital and Medical Center, Burlington, MA

Rogerio Souza

Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo

Aaron B. Waxman

Brigham and Woman’s Hospital, Harvard Medical School, Boston

Victor M. Moles

Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor

Laurent Savale

INSERM, UMR_S 999, Pulmonary Hypertension: Pathophysiology and Novel Therapies (HPPIT)

Carmine Dario Vizza

Department of Clinical Internal, Anesthesiologic, and Cardiovascular Science, Sapienza University of Rome, Rome

Stephan Rosenkranz

Materials Science Division

YaRu Shi

Barry Miller

Merck, Rahway, NJ

Harald S. Mackenzie

Merck, Rahway, NJ

Samuel S. Kim

Merck, Rahway, NJ

Maria José Loureiro

Merck, Rahway, NJ

Mahesh J. Patel

Merck, Rahway, NJ

Joerg Koglin

Merck, Rahway, NJ

Alexandra G. Cornell

Merck, Rahway, NJ

Marius M. Hoeper

Hannover Medical School and the German Center for Lung Research, Hannover, Germany